AF and Anticoagulation ✅

Related Subjects: | Atrial Flutter | Atrial Fibrillation | AF and Anticoagulation | AF and Rate Control | AF and Rhythm Control and Cardioversion | AF ECG | DC Cardioversion

🧠 Stroke Risk Assessment in AF

• 📊 Use CHA₂DS₂-VASc for non-valvular AF to guide anticoagulation.
• 💊 Warfarin reduces stroke risk by ~66%; DOACs offer similar or better stroke protection with lower ICH risk.
• 🩸 Assess bleeding risk using HAS-BLED. High score prompts review of modifiable factors, not withholding anticoagulation.

🧮 CHADS₂ Score

• 💔 Congestive heart failure/LV dysfunction: +1
• 🩺 Hypertension: +1
• 🎂 Age ≥ 75 years: +1
• 🍬 Diabetes mellitus: +1
• 🧠 Prior Stroke/TIA: +2

📈 CHADS₂ Event Rates

• 0–1: ⚖️ 1.9–2.8% per 100 patient-years
• 2–4: 📉 4.0–5.9% per 100 patient-years
• 5–6: 🚨 12.5–18.2% per 100 patient-years

🧮 CHA₂DS₂-VASc Score

• 💔 CHF/LV dysfunction: +1
• 🩺 Hypertension: +1
• 🎂 Age ≥ 75: +2
• 🎂 Age 65–74: +1
• 🍬 Diabetes mellitus: +1
• 🫀 Vascular disease (MI, PAD, aortic plaque): +1
• 🧠 Prior Stroke/TIA/TE: +2
• 👩 Female sex: +1

📊 CHA₂DS₂-VASc Event Rates

• 0–1: ⚖️ Low risk, 0–1.6% per 100 pt-years
• 2–4: 📉 Moderate risk, 2–6% per 100 pt-years
• ≥5: 🚨 High risk, 8–15% per 100 pt-years

💊 Anticoagulation Recommendations (NICE NG196)

• Score 0: 🚫 No anticoagulation
• Score 1 (male): 🤔 Consider anticoagulation
• Score 1 (female, only sex-related): ❌ No anticoagulation
• Score ≥2: ✅ Anticoagulation recommended
• 💊 First-line: DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)
• ⚠️ Warfarin: Only for mechanical valves, moderate/severe mitral stenosis, or DOAC contraindications
• 🩺 Adjust DOAC dose for renal impairment or low body weight

🩹 Bleeding Risk Assessment (HAS-BLED)

• H – Hypertension uncontrolled: +1
• A – Abnormal renal/liver function: +1 each
• S – Stroke history: +1
• B – Bleeding tendency or predisposition: +1
• L – Labile INR (if on warfarin): +1
• E – Elderly (age >65): +1
• D – Drugs/alcohol: +1 each

⚠️ High HAS-BLED score (≥3) → review modifiable risk factors, do NOT automatically withhold anticoagulation.

💊 Anticoagulant Options

🔑 Clinical Pearls

• Bleeding and stroke risks overlap – don’t use HAS-BLED to deny anticoagulation; instead use it to mitigate risks.
• DOACs are preferred first-line (NICE NG196, 2021) unless contraindicated (e.g. valvular AF, severe renal impairment).
• Warfarin still used in mechanical valves or severe mitral stenosis.
• Reversal agents are now available for both warfarin and DOACs.

🩺 Case Examples

Case 1 – Young Patient, Low Stroke Risk

58-year-old man with paroxysmal AF, no hypertension, diabetes, heart failure, or vascular disease. CHA₂DS₂-VASc = 0 Management: 📝 No anticoagulation needed. Focus on lifestyle optimization: BP, weight, alcohol, OSA. Rationale: ⚖️ Stroke risk very low (<1%/year), anticoagulation not beneficial.

Case 2 – Older Patient with Risk Factors

74-year-old woman with persistent AF, hypertension, type 2 diabetes. CHA₂DS₂-VASc = 4 Management: 💊 Start anticoagulation (DOAC preferred; warfarin if renal dysfunction). Monitor renal function and bleeding risk. Rationale: ✅ High stroke risk, anticoagulation provides substantial benefit (~65% relative risk reduction).

Case 3 – Frail Patient with Falls

82-year-old man, permanent AF, previous TIA, hypertension, moderate frailty, history of falls. CHA₂DS₂-VASc = 5; HAS-BLED = 3 Management: ⚖️ Anticoagulation still offered (DOAC at adjusted dose preferred). Review medications, monitor renal function, fall risk mitigation. Rationale: ✅ Stroke risk outweighs bleeding risk; falls alone rarely contraindicate anticoagulation.

🛠️ Rate & Rhythm Control Overview

• 🎛️ Rate control: β-blockers (bisoprolol, metoprolol), non-DHP CCBs (diltiazem, verapamil), digoxin (esp. in HF)
• 🎯 Target HR: <110 bpm (lenient) or <80 bpm if symptomatic)
• 🔄 Rhythm control: consider in symptomatic or younger patients
• 💊 Antiarrhythmics: Class I (flecainide, propafenone) if no structural heart disease; Class III (amiodarone, sotalol) if structural disease present
• ⚡ Electrical cardioversion (DCCV) under sedation if acute onset or unstable
• 🔥 Catheter ablation for recurrent symptomatic AF

🌱 Lifestyle & Comorbidity Management

• 🏃 Encourage moderate exercise; avoid excess high-intensity activity
• 🍷 Limit alcohol
• 💤 Treat OSA (CPAP), optimise sleep hygiene
• 📉 Control BP and diabetes
• ⚖️ Weight management
• 🚭 Smoking cessation

📚 References

• NICE NG196: Atrial fibrillation (2021)
• 2019 AHA/ACC/HRS AF Guidelines
• CHA₂DS₂-VASc Validation Study